EVERSANA, while being formed, realized that its customers needed patient-centered, value-based care. EVERSANA combines the leading global life science services into an integrated, independent and intelligent commercialization platform.
EVERSANA offers a fully integrated commercial services platform designed to solve patient support, distribution, field force, compliance and marketing challenges in an integrated way. EVERSANA’s services range from clinical trial recruitment to long-term therapy adherence which ensures that that the company is patient-centered.
To further achieve the company’s mission to deeply understand the patient journey, EVERSANA recently launched EVERSANA ENGAGE, a full-solution healthcare marketing agency uniquely designed to help pharmaceutical and biotechnology companies cohesively reach patients, providers and payers to enhance the patient experience and improve outcomes.
EVERSANA ENGAGE combines EVERSANA’s market access, healthcare provider, and patient-focused marketing services into a singular entity with more than 170 marketing experts worldwide, creating one of the larger life science marketing firms. From access solutions to branded and unbranded campaigns, the agency will offer a strong portfolio of agency services including creative, digital, strategy, policy, analytics and content development.
EVERSANA also announced a collaboration with Noom, a leading behavior change company, to increase medication adherence and improve health outcomes for the millions of patients suffering from chronic conditions and rare diseases worldwide.
The partnership combines EVERSANA’s fully integrated patient services model with Noom’s digital therapeutic platform. Noom’s program is based on cognitive behavior therapy and focuses on increasing patient engagement and improving clinical outcomes by leveraging human coaches and artificial intelligence.
Takeaway: EVERSANA’s mission is to deeply understand the patient journey.